Form 4: Ardelix CEO Michael Raab Sells 3,000 Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Ardelix's President and CEO, Michael Raab, executed a sale of 3,000 common stock shares at $6.07 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Michael Raab, President and CEO of Ardelix, Inc., sold 3,000 shares of common stock on September 26, 2024.
- The sale was executed at a price of $6.07 per share.
- The transaction was conducted under a pre-existing 10b5-1 trading plan adopted on December 13, 2023.
- Following the transaction, Raab directly owns 1,217,608 shares of Ardelix common stock.
- Raab also indirectly owns 24,364 shares through a family trust and 1,000 shares through trusts for his children.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine transaction under a pre-existing trading plan. There is no indication of positive or negative implications for the company.
Industry Context
This is a routine Form 4 filing, indicating insider trading activity. It's common for executives to sell shares under pre-arranged 10b5-1 trading plans to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by the CEO could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| July 25, 2012 | Date of the Michael G. Raab Living Trust |
| December 13, 2023 | Date the Reporting Person adopted the 10b5-1 trading plan |
| September 26, 2024 | Date of the stock sale transaction |
| September 27, 2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.